Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China.
Int J Mol Sci. 2020 Oct 5;21(19):7356. doi: 10.3390/ijms21197356.
Myeloid-derived suppressor cells (MDSCs) are major immunosuppressive cells in the tumor microenvironment (TME). During the differentiation and development of MDSCs from myeloid progenitor cells, their functions are also affected by a series of regulatory factors in the TME, such as metabolic reprogramming, epigenetic modification, and cell signaling pathways. Additionally, there is a crosstalk between these regulatory factors. This review mainly introduces the metabolism (especially glucose metabolism) and significant epigenetic modification of MDSCs in the TME, and briefly introduces the connections between metabolism and epigenetic modification in MDSCs, in order to determine the further impact on the immunosuppressive effect of MDSCs, so as to serve as a more effective target for tumor therapy.
髓系来源的抑制性细胞(MDSCs)是肿瘤微环境(TME)中的主要免疫抑制细胞。在 MDSCs 从髓系祖细胞分化和发育的过程中,其功能也受到 TME 中一系列调节因子的影响,如代谢重编程、表观遗传修饰和细胞信号通路。此外,这些调节因子之间存在相互作用。本综述主要介绍了 MDSCs 在 TME 中的代谢(特别是葡萄糖代谢)和显著的表观遗传修饰,并简要介绍了代谢和 MDSCs 中表观遗传修饰之间的联系,以确定其对 MDSCs 免疫抑制作用的进一步影响,从而为肿瘤治疗提供更有效的靶点。